Published in Medical Letter on the CDC and FDA, August 13th, 2006
According to recent research from England, "Supercritical carbon dioxide (sc-CO2 ) was used to impregnate indomethacin (a non-steroidal anti-inflammatory drug) into chitosan thermosets for the preparation of controlled release formulations. The products were analyzed by a range of methods including powder X-ray diffraction (XRD) and scanning electron microscopy (SEM)."
"The effects of the experimental temperature and pressure of the SC-CO2 on the thermal behavior of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.